LARIMAR THERAPEUTICS, INC. (LRMR)
Larimar Therapeutics Reports Positive Open Label Data and Submission of First Module of Rolling BLA for Accelerated Approval of Nomlabofusp for Friedreich’s Ataxia
Larimar Therapeutics Reports Positive Open Label Data and Submission of First Module of Rolling BLA for Accelerated Approval of Nomlabofusp for Friedreich’s Ataxia
Collective Mining Discovers a New Tungsten Enriched High-Grade Subzone 300 Meters Below Surface at Apollo by Drilling 27.35 m at 37.55 g/t AuEq (1.68% WO3, 11.62 g/t Au, 54 g/t Ag, 0.43% Cu)
FTAI Infrastructure Announces Acquisition of Tidewater Logistics
HONEYWELL TECHNOLOGIES LAUNCHES AS INDEPENDENT, PURE-PLAY AUTOMATION COMPANY FOLLOWING COMPLETION OF HONEYWELL AEROSPACE SPIN-OFF
Walker & Dunlop Arranges $191 Million Refinance for Office Portfolio Throughout Netherlands
United Therapeutics Corporation Announces FDA Approval of the LungFX™ Device for Centralized Ex Vivo Lung Perfusion
Diana Shipping Inc. Announces Extension of Tender Offer for All Outstanding Shares of Genco Shipping & Trading
Midnight Sun Continues Rapid Strike Expansion at Dumbwa; Now 6.7 Kilometres of Near-Surface Copper Mineralization
Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: Change in Interest of Director and CEO, Mr William Nursalim alias William Liem
Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: Notification Form for Director in respect of Interests in Securities